Real-World Clinical Effectiveness of Liraglutide 3.0 mg for Weight Management in Canada.
Journal
Obesity (Silver Spring, Md.)
ISSN: 1930-739X
Titre abrégé: Obesity (Silver Spring)
Pays: United States
ID NLM: 101264860
Informations de publication
Date de publication:
06 2019
06 2019
Historique:
received:
05
12
2018
accepted:
21
02
2019
pubmed:
8
5
2019
medline:
12
3
2020
entrez:
8
5
2019
Statut:
ppublish
Résumé
Real-world clinical effectiveness of liraglutide 3.0 mg, in combination with diet and exercise, was investigated 4 and 6 months post initiation. Changes in absolute and percent body weight were examined from baseline. A cohort of liraglutide 3.0 mg initiators in 2015 and 2016 was identified from six Canadian weight-management clinics. Post initiation values at 4 and 6 months were compared with baseline values using a paired t test. The full cohort consisted of 311 participants, with 210 in the ≥ 4-month persistence group and 167 in the ≥ 6-month persistence group. Average baseline BMI was 40.7 kg/m In a real-world setting, liraglutide 3.0 mg, when combined with diet and exercise, was associated with clinically meaningful weight loss.
Identifiants
pubmed: 31062937
doi: 10.1002/oby.22462
pmc: PMC6593982
doi:
Substances chimiques
Hypoglycemic Agents
0
Liraglutide
839I73S42A
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
917-924Commentaires et corrections
Type : CommentIn
Type : CommentIn
Informations de copyright
© 2019 The Authors. Obesity published by Wiley Periodicals, Inc. on behalf of The Obesity Society (TOS).
Références
J Diabetes Sci Technol. 2015 Jul 16;10(1):164-74
pubmed: 26183599
Lancet Diabetes Endocrinol. 2014 Jun;2(6):474-80
pubmed: 24731674
QJM. 2006 Sep;99(9):565-79
pubmed: 16916862
N Engl J Med. 2015 Jul 2;373(1):11-22
pubmed: 26132939
Int J Obes (Lond). 2014 Jun;38(6):784-93
pubmed: 23999198
BMJ Open. 2012 May 11;2(3):
pubmed: 22581797
Diabetes Care. 2011 Jul;34(7):1481-6
pubmed: 21593294
Obesity (Silver Spring). 2019 Jan;27(1):7-9
pubmed: 30569641
N Engl J Med. 2002 Feb 7;346(6):393-403
pubmed: 11832527
J Health Psychol. 2013 Apr;18(4):574-86
pubmed: 22843633
Lancet. 2009 Mar 28;373(9669):1083-96
pubmed: 19299006
CMAJ. 2007 Apr 10;176(8):S1-13
pubmed: 17420481
Am J Clin Nutr. 2001 Nov;74(5):579-84
pubmed: 11684524
J Am Coll Nutr. 2009 Apr;28(2):159-68
pubmed: 19828901
Am J Clin Nutr. 1992 Aug;56(2):320-8
pubmed: 1386186
Can J Surg. 2012 Aug;55(4):239-43
pubmed: 22617538
Int J Behav Med. 2010 Sep;17(3):176-81
pubmed: 20033629
Int J Obes (Lond). 2008 Sep;32(9):1431-7
pubmed: 18607383
Health Rep. 2006 Aug;17(3):9-25
pubmed: 16981483
BMC Obes. 2016 Mar 09;3:14
pubmed: 26966544
Int J Obes (Lond). 2006 Jul;30(7):1132-7
pubmed: 16432536
Endocr Pract. 2012 Sep-Oct;18(5):642-8
pubmed: 23047927
Obes Rev. 2014 Mar;15(3):169-82
pubmed: 24118750
Clin Pharmacol Ther. 2016 Aug;100(2):147-59
pubmed: 26916672
J Clin Endocrinol Metab. 2015 Feb;100(2):342-62
pubmed: 25590212
Int J Clin Pract Suppl. 2010 Oct;(167):4-11
pubmed: 20887299
Obes Res. 2003 Jul;11(7):888-94
pubmed: 12855759